Long-Term Outcomes of Carotid Endarterectomy and Carotid Artery Stenting When Performed by a Single Vascular Surgeon

Abstract

Objectives:

Carotid artery endarterectomy (CEA) and carotid artery stenting (CAS) are 2 effective treatment options for carotid revascularization and stroke prevention. The long-term outcomes of Carotid Revascularization Endarterectomy versus Stenting Trial (CREST) reported similar stroke and death rate between the 2 procedures. This study presents the short- and long-term outcomes of CEA and CAS of all risk patients performed by a single vascular surgeon in a real-world setting.

Methods:

We retrospectively reviewed all patients who underwent CEA and CAS from September 2005 to June 2017 at our institute. Student t test, χ², and Fisher exact tests were used to compare patient’s characteristics. Multivariate logistic, cox regression models and survival analysis were used to compare postoperative and long-term outcomes between the 2 groups.

Results:

Over 2000 patients were evaluated for carotid artery stenosis during the study period, and 313 revascularization procedures were performed (CEA: 47%, CAS: 53%). Patients’ age (Mean [95% confidence interval, CI] 68.8 [67.2-70.4] vs 69.7 [68.2-71.3], P = .40) was similar between CEA and CAS. Patients who underwent CAS had significantly higher comorbidities (chronic obstructive pulmonary disease [COPD], chronic heart failure [CHF], hyperlipidemia, and prior ipsilateral intervention, all P < .05). No difference was found in 30-day complications after CEA versus CAS including stroke (2.0% vs 1.2%), myocardial infarction (MI; 0.7% vs 1.2%), death (0% vs 1.2%) as well as combined major adverse events (stroke/death/MI; 2.7% vs 3.0%; all P > .05). Overall 7-year survival, stroke-free survival and restenosis-free survival were similar between the 2 groups (P > .5). Significant predictors of mortality were diabetes (hazard ratio, HR [95% CI]: 2.41 [1.15-5.08]), chronic kidney disease (HR [95% CI]: 4.89 [1.97-12.13]), and COPD (HR [95% CI]: 3.31 [1.43-7.71]; all P values <.05). Statin use was protective with 71% reduction in risk of mortality (HR [95% CI]: 0.29 [0.12-0.67], P = .004).

Conclusion:

Our experience showed comparable short- and long-term outcomes of CAS and CEA performed for carotid artery stenosis by vascular surgeon. There was no difference between single institutional long-term outcomes and CREST outcomes following CEA and CAS.

Keywords

CEA CAS long-term outcomes

Get full access to this article

View all access options for this article.

References

Sardar

Chatterjee

Aronow

. Carotid artery stenting versus endarterectomy for stroke prevention: a meta-analysis of clinical trials. J Am Coll Cardiol. 2017;69(18):2266–2275.

Moresoli

Habib

Reynier

Secrest

Eisenberg

Filion

. Carotid stenting versus endarterectomy for asymptomatic carotid artery stenosis: a systematic review and meta-analysis. Stroke. 2017;48(8):2150–2157.

Brott

Hobson

2nd Howard

. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med. 2010;363(1):11–23.

Brott

Howard

Roubin

. Long-term results of stenting versus endarterectomy for carotid-artery stenosis. N Engl J Med. 2016;374(11):1021–1031.

Grimm

Arhuidese

Beaulieu

. Surgeon’s 30-day outcomes supporting the carotid revascularization endarterectomy versus stenting trial. JAMA Surg. 2014;149(12):1314–1318.

Gahremanpour

Perin

Silva

. Carotid artery stenting versus endarterectomy: a systematic review. Tex Heart Inst J. 2012;39(4):474–487.

Van Damme

Limet

. Lessons learnt from carotid artery trials. Acta Chir Belg. 2006;106(5):489–499.

Hicks

Talbott

Canner

. Risk of disease progression in patients with moderate asymptomatic carotid artery stenosis: implications of tobacco use and dual antiplatelet therapy. Ann Vasc Surg. 2015;29(1):1–8.

Hicks

Canner

Arhuidese

. Development of a duplex-derived velocity risk prediction model of disease progression in patients with moderate asymptomatic carotid artery stenosis. J Vasc Surg. 2014;60(6):1585–1592.

10.

Arhuidese

Obeid

Nejim

Locham

Hicks

Malas

. Stenting versus endarterectomy after prior ipsilateral carotid endarterectomy. J Vasc Surg. 2017;65(1):1–11.

11.

Arhuidese

Rizwan

Nejim

Malas

. Outcomes of primary and secondary carotid artery stenting. Stroke. 2017;48(11):3086–3092.

12.

Arhuidese

Faateh

Nejim

Locham

Abularrage

Malas

. Risks associated with primary and redo carotid endarterectomy in the endovascular era. JAMA Surg. 2017;153(3):252–259.

13.

Nejim

Dakour Aridi

Locham

Arhuidese

Hicks

Malas

. Carotid artery revascularization in patients with contralateral carotid artery occlusion: stent or endarterectomy? J Vasc Surg. 2017;66(6):1735–1748. e1.

14.

Voeks

Howard

Roubin

. Age and outcomes after carotid stenting and endarterectomy: the carotid revascularization endarterectomy versus stenting trial. Stroke. 2011;42(12):3484–3490.

15.

Obeid

Arhuidese

Gaidry

. Beta-blocker use is associated with lower stroke and death after carotid artery stenting. J Vasc Surg. 2016;63(2):363–369.

16.

Rizwan

Faateh

Dakour-Aridi

Nejim

Alshwaily

Malas

. Statins reduce mortality and failure to rescue after carotid artery stenting. J Vasc Surg. 2019;69(1):112–119.

17.

Perler

. Should statins be given routinely before carotid endarterectomy? Perspect Vasc Surg Endovasc Ther. 2007;19(3):240–245.

18.

Malas

Glebova

Hughes

. Effect of patching on reducing restenosis in the carotid revascularization endarterectomy versus stenting trial. Stroke. 2015;46(3):757–761.

19.

Obeid

Arnaoutakis

Arhuidese

. Poststent ballooning is associated with increased periprocedural stroke and death rate in carotid artery stenting. J Vasc Surg. 2015;62(3):616–623. e1.

20.

Malas

Leal

Kashyap

Cambria

Kwolek

Criado

. Technical aspects of transcarotid artery revascularization using the ENROUTE transcarotid neuroprotection and stent system. J Vasc Surg. 2017;65(3):916–920.

21.

Alpaslan

Wintermark

Pinter

Macdonald

Ruedy

Kolvenbach

. Transcarotid artery revascularization with flow reversal. J Endovasc Ther. 2017;24(2):265–270.

22.

Hill

Brooks

Mackey

. Stroke after carotid stenting and endarterectomy in the carotid revascularization endarterectomy versus stenting trial (CREST). Circulation. 2012;126(25):3054–3061.

23.

Huibers

Calvet

Kennedy

. Mechanism of procedural stroke following carotid endarterectomy or carotid artery stenting within the international carotid stenting study (ICSS) randomised trial. Eur J Vasc Endovasc Surg. 2015;50(3):281–288.

24.

AbuRahma

Campbell

Hariri

. Clinical outcome of carotid artery stenting according to provider specialty and volume. Ann Vasc Surg. 2017;44:361–367.

25.

Dua

Romanelli

Uochurch

Jr . Predictors of poor outcome after carotid intervention. J Vasc Surg. 2016;64(3):663–670. doi: 10.1016/j.jvs.2016.03.428. Epub 2016 May 18.

26.

Giles

Hamdan

Pomposelli

Wyers

Schermerhorn

. Stroke and death after carotid endarterectomy and carotid artery stenting with and without high risk criteria. J Vasc Surg. 2010;52(6):1497–1504.

27.

Vogel

Dombrovskiy

Haser

Graham

. Carotid artery stenting: impact of practitioner specialty and volume on outcomes and resource utilization. J Vasc Surg. 2009;49(5):1166–1171.

28.

Sgroi

Darby

Kabutey

Barleben

Lane

3rd Fujitani

. Experience matters more than specialty for carotid stenting outcomes. J Vasc Surg. 2015;61(4):933–938.

29.

Hopkins

Roubin

Chakhtoura

. The carotid revascularization endarterectomy versus stenting trial: credentialing of interventionalists and final results of lead-in phase. J Stroke Cerebrovasc Dis. 2010;19(2):153–162.